FDA Should Release Existing Supply Of Primatene Mist OTC Asthma Inhaler, Rep. Says
This article was originally published in The Pink Sheet Daily
Lawmakers seek to restore the availability of Primatene Mist while the absence of an alternative OTC asthma remedy persists.
You may also be interested in...
The only inhalers to treat asthma available after Dec. 31 will be prescription products.
Homeopathic firm TheraBiogen plans to roll out products “every six to nine months” to add to its existing lineup of homeopathic remedies for allergy and cold and flu, says CEO Kelly Hickel. The firm also counts on sales growth from a social media campaign to explain what is not in its products as well as what is.